Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Jeremy

Showing results (21-30 of 116) with videos related to

Pageof 12
Sort By:
The Medical Journal of Australia|April 24, 1971
Studies of serum urate levels in New Guineans living in different environmentsR Jeremy, F A Rhodes
Drug Development Research|October 11, 2018
Microbial esterases and ester prodrugs: An unlikely marriage for combating antibiotic resistanceErik M Larsen, R Jeremy Johnson
The Australian & New Zealand Journal of Obstetrics & Gynaecology|May 1, 1992
Alcoholic liver disease with subsequent hyperoestrogenismC de Costa, R Jeremy, P Russell
Cancer Nanotechnology|August 29, 2015
Size-dependent cellular toxicity and uptake of commercial colloidal gold nanoparticles in DU-145 cellsPallavi Vedantam, George Huang, T R Jeremy Tzeng
Molecular Biology of the Cell|February 24, 2006
The vaccinia-related kinases phosphorylate the N' terminus of BAF, regulating its interaction with DNA and its retention in the nucleusR Jeremy Nichols, Matthew S Wiebe, Paula Traktman
The Australian and New Zealand Journal of Surgery|December 1, 1973
The role of fluorine i8 scanning in the detection of skeletal metastases in early breast cancerD Green, R Jeremy, J Towson, et al.
International Journal of Molecular Sciences|January 26, 2021
Genetic and Environmental Factors Influence the Pleomorphy of <i>LRRK2</i> ParkinsonismVinita G Chittoor-Vinod, R Jeremy Nichols, Birgitt Schüle
Biochemistry|October 25, 2007
Intraspecies regulation of ribonucleolytic activityR Jeremy Johnson, Luke D Lavis, Ronald T Raines
Frontiers in Neurology|November 17, 2022
Development of mutation-selective LRRK2 kinase inhibitors as precision medicine for Parkinson's disease and other diseases for which carriers are at increased riskRobert K Lesniak, R Jeremy Nichols, Thomas J Montine
Molecules (Basel, Switzerland)|July 27, 2024
Shifting Mycobacterial Serine Hydrolase Activity Visualized Using Multi-Layer In-Gel Activity AssaysAllison L Goss, Renee E Shudick, R Jeremy Johnson
Pageof 12

Showing results (21-30 of 116) with videos related to

Sort By:
Pageof 12
The Medical Journal of Australia|April 24, 1971
Studies of serum urate levels in New Guineans living in different environmentsR Jeremy, F A Rhodes
Drug Development Research|October 11, 2018
Microbial esterases and ester prodrugs: An unlikely marriage for combating antibiotic resistanceErik M Larsen, R Jeremy Johnson
The Australian & New Zealand Journal of Obstetrics & Gynaecology|May 1, 1992
Alcoholic liver disease with subsequent hyperoestrogenismC de Costa, R Jeremy, P Russell
Cancer Nanotechnology|August 29, 2015
Size-dependent cellular toxicity and uptake of commercial colloidal gold nanoparticles in DU-145 cellsPallavi Vedantam, George Huang, T R Jeremy Tzeng
Molecular Biology of the Cell|February 24, 2006
The vaccinia-related kinases phosphorylate the N' terminus of BAF, regulating its interaction with DNA and its retention in the nucleusR Jeremy Nichols, Matthew S Wiebe, Paula Traktman
The Australian and New Zealand Journal of Surgery|December 1, 1973
The role of fluorine i8 scanning in the detection of skeletal metastases in early breast cancerD Green, R Jeremy, J Towson, et al.
International Journal of Molecular Sciences|January 26, 2021
Genetic and Environmental Factors Influence the Pleomorphy of <i>LRRK2</i> ParkinsonismVinita G Chittoor-Vinod, R Jeremy Nichols, Birgitt Schüle
Biochemistry|October 25, 2007
Intraspecies regulation of ribonucleolytic activityR Jeremy Johnson, Luke D Lavis, Ronald T Raines
Frontiers in Neurology|November 17, 2022
Development of mutation-selective LRRK2 kinase inhibitors as precision medicine for Parkinson's disease and other diseases for which carriers are at increased riskRobert K Lesniak, R Jeremy Nichols, Thomas J Montine
Molecules (Basel, Switzerland)|July 27, 2024
Shifting Mycobacterial Serine Hydrolase Activity Visualized Using Multi-Layer In-Gel Activity AssaysAllison L Goss, Renee E Shudick, R Jeremy Johnson
Pageof 12